Wednesday, March 16, 2011

From a PPROM survivor

As I lay in a hospital bed for 62 days, praying and hoping that my baby would survive in my womb without adequate levels of amniotic fluid, due to premature rupture of membranes (PPROM) at 23 weeks and 1 day pregnant, I was barely able to grasp the magnitude of the situation for her health. While we were extremely fortunate that Rachael survived (and is now thriving), there are many families who face great loss because of PPROM. For a woman who goes through a pregnancy marked with PPROM, the prospect of another pregnancy is freightening, as PPROM does recur.
After the initial shock of our current pregnancy subsided, the real questions began: what if IT (PPROM) happens again? What if we lose this baby? What if we aren't so fortunate the second time around? (Fortunate, to deliver  3lb, 6oz baby who spent 51 days in a NICU).
I was thankful to my medical team at Duke to agree that the use of P17 (a weekly injection, taken in weeks 16-26 of pregnancy) which has been shown to reduce the recurrence of PPROM by 30% was a good treatment option for me. I was given a script and paid $90 for the entire 10 weeks of the medication.

Well, now the production of this medication (which was compounded in individual pharmacies) has now been approved through the FDA to one drug maker, who is charging obscene amounts of money for this treatment. See the link below for more details as well as the steps below that you can take to stand up against this process which will keep MANY (most) families from having access to this vital drug for pregnancy survival.

The logic doesn't work out -- if PPROM prone women do NOT get this drug, the alternative is a marked increase in NICU stays. Rachael's 51 day stay was billed to our insurance at almost $500,000  --- so, taking AWAY a drug that would cost the patient $90-100 and insure the longevity of her pregnancy is ABSURD!

http://www.msnbc.msn.com/id/41994697/

First, contact KV Pharmaceutical and voice your displeasure:

KV Pharmaceuticals Contact Information: investorrelations@kvpharmaceutical.com
Second, notify your local media outlets about this issue.
Third, write or email your congressman and senator:
http://www.senate.gov/general/contact_information/senators_cfm.cfm
https://writerep.house.gov/writerep/welcome.shtml
Fourth, contact the FDA and find out why they elected to give KV exclusivity for this product. Competition will bring down the price dramatically.
http://www.fda.gov/AboutFDA/ContactFDA/default.htm
Fifth, write to the president:
http://www.whitehouse.gov/contact
Sixth, contact your state Medicaid offices and your insurance carriers. Get them involved
Seventh, get as many of your friends, family members, co-workers, etc. as possible to do the above.
Eighth, feel free to cut/paste/email the above to as many contacts as you can.

No comments: